Holds one active US DMF for scopolamine, filing since 2011. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for scopolamine, filing since 2016. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for scopolamine, filing since 2015. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for scopolamine, filing since 1988.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for scopolamine and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2026 YTD | $1222.20 | 27 |
| 2025 | $1207.32 | 67 |
| 2024 | $1156.23 | 51 |
| 2023 | $1182.27 | 54 |
US dollars per kilogram, customs export unit values.